Ysios news
04.12.19
Anaconda biomed secures €20 million round of funding
16.07.19
AM-Pharma Raises €116m [$133m] to Conduct Pivotal Phase III Trial of recAP in Acute Kidney Injury
portfolio news
07.01.20
Galecto and PharmAkea merge to create strong clinical-stage company developing first-in-class therapeutics in fibrosis and cancer
04.12.19
Anaconda biomed secures €20 million round of funding
